Emerald Mutual Fund Advisers Trust Black Diamond Therapeutics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$26.17 - $43.07 $2.8 Million - $4.61 Million	-107,060 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$22.3 - $44.8 $80,302 - $161,324	-3,601 Reduced 3.25%	107,060 $4.51 Million
Q1 2020 Apr 30, 2020	BUY	$18.18 - $39.48 $2.01 Million - $4.37 Million	110,661 New	110,661 $2.76 Million

121

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $89.4M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.